001448619 000__ 06001cam\a2200601\a\4500
001448619 001__ 1448619
001448619 003__ OCoLC
001448619 005__ 20230310004248.0
001448619 006__ m\\\\\o\\d\\\\\\\\
001448619 007__ cr\un\nnnunnun
001448619 008__ 220806s2022\\\\sz\\\\\\o\\\\\000\0\eng\d
001448619 019__ $$a1338831192
001448619 020__ $$a9783031118029$$q(electronic bk.)
001448619 020__ $$a3031118022$$q(electronic bk.)
001448619 020__ $$z9783031118012$$q(print)
001448619 020__ $$z3031118014
001448619 0247_ $$a10.1007/978-3-031-11802-9$$2doi
001448619 035__ $$aSP(OCoLC)1338839272
001448619 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dGW5XE$$dYDX$$dOCLCQ$$dOCLCF$$dN$T$$dOCLCQ
001448619 049__ $$aISEA
001448619 050_4 $$aRJ506.H9
001448619 08204 $$a616.85/89$$223/eng/20220815
001448619 24500 $$aNew discoveries in the behavioral neuroscience of attention-deficit hyperactivity disorder /$$cS Clare Stanford, Emma Sciberras, editors.
001448619 260__ $$aCham :$$bSpringer,$$c2022.
001448619 300__ $$a1 online resource (503 pages)
001448619 336__ $$atext$$btxt$$2rdacontent
001448619 337__ $$acomputer$$bc$$2rdamedia
001448619 338__ $$aonline resource$$bcr$$2rdacarrier
001448619 4901_ $$aCurrent Topics in Behavioral Neurosciences ;$$vv. 57
001448619 500__ $$a2.3 Summary: Methylphenidate and the Catecholamine Systems
001448619 5050_ $$aIntro -- Preface -- Contents -- ADHD in Children and Adults: Diagnosis and Prognosis -- 1 Introduction -- 2 Diagnosis -- 3 ADHD in Preschool Children -- 4 ADHD in School-Aged Children -- 5 ADHD in Adolescents -- 6 ADHD in Adults -- 7 Conclusion -- References -- Current Pharmacological Treatments for ADHD -- 1 Introduction -- 2 Medications for ADHD and Their Mechanism of Action -- 2.1 Stimulant Medications -- 2.1.1 Methylphenidate -- 2.1.2 Amphetamine -- 2.2 Nonstimulants -- 2.2.1 Atomoxetine -- 2.2.2 Guanfacine and Clonidine -- 3 Pharmacokinetics of ADHD Medications
001448619 5058_ $$a4 ADHD Medications and the Cognitive Neuroscience of ADHD -- 5 Efficacy and Tolerability: Comparison Between Medications -- 6 Effects of ADHD Medications on Other Outcomes and Comorbidities -- 7 Factors to Consider When Choosing Treatments -- 8 Conclusions -- References -- The Benefits and Limitations of Stimulants in Treating ADHD -- 1 Introduction -- 2 Stimulants Used to Treat ADHD -- 3 Political, Ethical, and Moral Issues Relating to the Use of Stimulants for the Treatment of ADHD -- 4 The Treatment of Subsyndromal ADHD and the Use of Stimulants as Cognitive Enhancers
001448619 5058_ $$a5 Comparative Efficacy Between Stimulants and Non-pharmacological Treatments for ADHD -- 6 Comparative Efficacy, Effectiveness, and Safety of Pharmacological Treatments for ADHD -- 6.1 Children and Adolescents -- 6.2 Adults -- 6.3 Comparisons Between Different Stimulant Formulations -- 7 Clinical Implications of These Findings -- 8 Monitoring Treatment Response and the Potential Benefits of Integrating Measurement-Based Care Approaches into Clinical Prac ... -- 9 Do Stimulants Work and Are They Safe Over the Long Term? -- 10 Considerations for Different Clinical Populations
001448619 5058_ $$a11 Summary and Conclusions -- References -- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development -- 1 Introduction -- 2 Current Status of Drugs to Treat ADHD -- 3 Non-clinical and Clinical Pharmacology of Approved Drugs to Treat ADHD -- 3.1 Lisdexamfetamine -- 3.2 Viloxazine -- 3.3 Prodrugs for Methylphenidate -- 3.4 Comment (Summary/Overview) -- 4 Update on the Progress of R & D in the Search for New Drugs to Treat ADHD -- 4.1 Centanafadine -- 4.2 Mazindol -- 4.3 Dasotraline -- 4.4 Vortioxetine -- 4.5 Droxidopa -- 4.6 Baicalin -- 4.7 Summary
001448619 5058_ $$a5 Progress in the Pharmacological Management of ADHD -- 5.1 Efficacy in ADHD -- 5.2 Once-Daily Medication -- 5.3 Relapse on Withdrawal -- 5.4 Drug-Induced Side Effects -- 5.5 Abuse Liability -- 6 The Link Between ADHD and Binge-Eating Disorder -- 7 Concluding Remarks -- References -- Effects of Methylphenidate on the Dopamine Transporter and Beyond -- 1 Introduction -- 2 Methylphenidate and the Central Catecholamine Systems -- 2.1 Methylphenidate and the Catecholamine Transporters -- 2.2 Methylphenidate and Other Catecholamine Protein Targets
001448619 506__ $$aAccess limited to authorized users.
001448619 520__ $$aNew Discoveries in the Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder reviews the latest developments in preclinical and clinical research of Attention Deficit Hyperactivity Disorder. As well as updating key chapters that were included in an earlier edition, this volume includes some new topics that are attracting a great deal of interest and point the way to new and promising directions for future research. The chapters follow five main themes: Current perspectives on the clinical profile of ADHD and its treatment, common co-occurring conditions, neurobiological studies examining brain function and genetics, animal and in vitro studies, and future directions. This combination of topics emphasises the translational relevance and validity of preclinical research so as to enable a better understanding of ADHD and to highlight the promising strategies for developing new treatments.
001448619 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 15, 2022).
001448619 650_0 $$aAttention-deficit hyperactivity disorder.
001448619 650_0 $$aAttention-deficit disorder in adults.
001448619 650_0 $$aClinical neuropsychology.
001448619 650_0 $$aNeuropsychiatry.
001448619 655_0 $$aElectronic books.
001448619 7001_ $$aStanford, S. Clare.
001448619 7001_ $$aSciberras, Emma.
001448619 77608 $$iPrint version:$$aStanford, S. Clare.$$tNew Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder.$$dCham : Springer International Publishing AG, ©2022$$z9783031118012
001448619 830_0 $$aCurrent topics in behavioral neurosciences ;$$vv. 57.
001448619 852__ $$bebk
001448619 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-11802-9$$zOnline Access$$91397441.1
001448619 909CO $$ooai:library.usi.edu:1448619$$pGLOBAL_SET
001448619 980__ $$aBIB
001448619 980__ $$aEBOOK
001448619 982__ $$aEbook
001448619 983__ $$aOnline
001448619 994__ $$a92$$bISE